Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
- PMID: 14642273
- DOI: 10.1016/s0896-6273(03)00627-5
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles
Abstract
Cyclin-dependent kinase 5 (Cdk5) and its regulatory subunit p35 are integral players in the proper development of the mammalian central nervous system. Proteolytic cleavage of p35 generates p25, leading to aberrant Cdk5 activation. The accumulation of p25 is implicated in several neurodegenerative diseases. In primary neurons, p25 causes apoptosis and tau hyperphosphorylation. Current mouse models expressing p25, however, fail to rigorously recapitulate these phenotypes in vivo. Here, we generated inducible transgenic mouse lines overexpressing p25 in the postnatal forebrain. Induction of p25 preferentially directed Cdk5 to pathological substrates. These animals exhibited neuronal loss in the cortex and hippocampus, accompanied by forebrain atrophy, astrogliosis, and caspase-3 activation. Endogenous tau was hyperphosphorylated at many epitopes, aggregated tau accumulated, and neurofibrillary pathology developed progressively in these animals. Our cumulative findings provide compelling evidence that in vivo deregulation of Cdk5 by p25 plays a causative role in neurodegeneration and the development of neurofibrillary pathology.
Similar articles
-
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.Nature. 1999 Dec 9;402(6762):615-22. doi: 10.1038/45159. Nature. 1999. PMID: 10604467
-
Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain.Neurosci Lett. 2001 Jun 22;306(1-2):37-40. doi: 10.1016/s0304-3940(01)01864-x. Neurosci Lett. 2001. PMID: 11403952
-
Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice.J Comp Neurol. 2002 May 6;446(3):257-66. doi: 10.1002/cne.10186. J Comp Neurol. 2002. PMID: 11932941
-
Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.Arch Med Res. 2012 Nov;43(8):655-62. doi: 10.1016/j.arcmed.2012.10.015. Epub 2012 Nov 7. Arch Med Res. 2012. PMID: 23142263 Free PMC article. Review.
-
Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.Biochim Biophys Acta. 2004 Mar 11;1697(1-2):143-53. doi: 10.1016/j.bbapap.2003.11.020. Biochim Biophys Acta. 2004. PMID: 15023357 Review.
Cited by
-
S-nitrosation of proteins relevant to Alzheimer's disease during early stages of neurodegeneration.Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4152-7. doi: 10.1073/pnas.1521318113. Epub 2016 Mar 24. Proc Natl Acad Sci U S A. 2016. PMID: 27035958 Free PMC article.
-
The Effects of SIRT1 on Alzheimer's Disease Models.Int J Alzheimers Dis. 2012;2012:509529. doi: 10.1155/2012/509529. Epub 2012 Dec 3. Int J Alzheimers Dis. 2012. PMID: 23251824 Free PMC article.
-
Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction.Elife. 2021 May 21;10:e65301. doi: 10.7554/eLife.65301. Elife. 2021. PMID: 34018922 Free PMC article.
-
Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.J Neurosci. 2013 Jan 2;33(1):334-43. doi: 10.1523/JNEUROSCI.3593-12.2013. J Neurosci. 2013. PMID: 23283346 Free PMC article.
-
Extracellular CIRP Induces Calpain Activation in Neurons via PLC-IP3-Dependent Calcium Pathway.Mol Neurobiol. 2023 Jun;60(6):3311-3328. doi: 10.1007/s12035-023-03273-3. Epub 2023 Feb 28. Mol Neurobiol. 2023. PMID: 36853429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials